medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Authors instructions        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 5

Med Int Mex 2012; 28 (5)

Urinary Tract Infections. In Vitro Resistance Pattern of E. coli ESBL Quinolone, Trimethoprim-Sulfamethoxazole and Nitrofuroantoin

Rendón MMA, Reyes AA, Rosas BJB, Rodríguez WF
Full text How to cite this article

Language: Spanish
References: 16
Page: 434-439
PDF size: 199.98 Kb.


Key words:

Urinary tract infection (IVU), E coli , E coliESBL, antimicrobial resistance Mexico.

ABSTRACT

Objective: To revise the resistance pattern of E. coli and E. coli BLEE (toward quinolones, nitrofurantoine and trimetoprima-sulfametoxazol) in all urocultives taken between August, 2011 and January, 2012 in Angeles del Pedregal Hospital.
Material and Method: It is a transversal cohort descriptive study. The inclusion criteria were positive urocultives taken between August 2011 up to January 2012, separated in 3 groups: Group A. external, Group B internal and Group C intensive care unit, intensive coronary care and pediatric intensive care unit.
Results: There were included 738 positive urocultives. In group A, TMP/SMZ showed a resistance of 56.46% and a quinolones resistance of (Levofloxacin 29.74%, Ciprofloxacin 8.18% and Norfloxacin 13.36%) and nitrofurantoin 8.18%. Group B presented a resistance of 71.69% to TMP/SMZ, to quinolones (levofloxacin 49.05%, Ciprofloxacin 43.49% and Norfloxacin 26.41%) and nitrofurantoin of 5.6%. In group C was founded a 66.6% resistance to TMP/SMZ, to quinolones (Levofloxacin 66.66%, Ciprofloxacin 66.66% and Norfloxacin 33.33%) and Nitrofurantoin 0%.
Conclusion: There is a high resistance toward TMP/SMZ in all hospital levels. The lower index of resistance in non-complicated, ambulatory UTIS is to ciprofloxacin. In-hospital, the lower resistance is to norfloxacin, while in the intensive care unit should be an individualized treatment.


REFERENCES

  1. Barragán AIA, Barriga G, Calderón F, y col. Primer Consenso Nacional de Manejo Antimicrobiano de Infecciones de Vías Urinarias en el Adulto. Boletín del Colegio Mexicano de Urología 2005;20(2):46-57.

  2. Ducel G, Fabry J, Nicolle L, y col Prevención de las infecciones nosocomiales. Guía Practica. WHO/CDS/EPH 2002;12

  3. Mehnert-kay, Susan MD. Diagnosis and Management of Uncomplicated Urinary Tract Infections. University of Oklahoma College of Medicine, Tulsa, Oklahoma. AAFP 2006;72(3):451-456.

  4. Turpin CA, Minkah B, Danso KA, Frimpong EH. Asymptomatic bacteriuria in pregnant women attending antenatal clinic at Komfo Anokye Teaching Hospital, Kumasi, Ghana. Ghana Med J 2007;41(1):26-29.

  5. Montini G, Tullus K, Hewitt I. Febrile Urinary Infection in Children. N Engl J Med 2011;365(3): 239-250.

  6. Craig JM, Simpson J, Williams G, et al. Antibiotic Prophylaxis and Recurrence Urinary Tract Infection in Children. N Eng J Med 2009;361:1748-1759.

  7. Manikandan S, Ganesapandian S, Singh Manoj, et al. Antimicrobial Susceptibility Pattern of Urinary Tract Infection Causing Human Pathogenic Bacteria. Asian Journal of Medical Sciences 2011;3(2):56-60.

  8. Manikandan S, Ganesapandian S, Singh Manoj, et al. Emerging of Multidrug Resistance Human Pathogens from Urinary Tract Infections. Current Research in Bacteriology 2011;4(1):9-15

  9. Scheaffer A. Chronic Prostatitis and the Chronic Pelvic Pain. N Engl J Med 2006; 355(16):1690-1698.

  10. Hooton T. Uncomplicated Urinary Tract Infection. N Engl J Med 2012;366(11):1028-1037.

  11. Nimri L, Batchoun R. Community-Aquired Urinary Tract Infections in Rural Area: Predominant Uropathogens, and their Antimicrobial Resistance. Webmed Central Microbiology 2010;1(9): WMC00679.

  12. Johnson JR, Menard M, Johnston M, et al. Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada 2002 to 2004. Antimicrob Agents Chemother 2009;53(7):2733-2739.

  13. Castellanos M, Cruz B, Dávalos M y col. Guía de Práctica Clínica: prevención, diagnóstico y tratamiento de la infección de vías urinarias no complicada en menores de 18 años en el primero y segundo nivel de atención. México: Secretaría de Salud, 2008.

  14. Medécigo A, Arrieta R, Cabrera L, y col. Guía de Práctica Clínica: diagnóstico y tratamiento de la infección del tracto urinario bajo durante el embarazo en el primer nivel de atención. México: Secretaría de Salud, 2008.

  15. Díaz Ponce H, Sandoval A. Infección de vías urinarias en pediatría. Enf Infec y Micro Biol 2002;22(1):14-19.

  16. Esquivel-Molina C, Barbachano-Rodríguez E, Ávila-Romero H, et al. Perfil microbiológico en infección urinaria asociada a catéter vesicouretral. MEDICRIT 2007;4(3):59-65.




2020     |     www.medigraphic.com

Mi perfil

CÓMO CITAR (Vancouver)

Med Int Mex. 2012;28